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Abstract The original article published by Cvar and Ryge
in 1971 on the US Public Health Service (USPHS)
Guidelines is virtually inaccessible to current scientists,
despite its remarkable impact on clinical dental research.
The original article described all the pilot studies that led to
the choices for the final USPHS guidelines. However,
many of the important basic ideas expressed in the original
article, such as evaluator calibration, have been overlooked
in recent years. Challenges for effective clinical testing of
restorative procedures and materials that were emphasized
by those authors are even more relevant today. Therefore, it
is totally appropriate to republish the original article by
Cvar and Ryge in this issue of Clinical Oral Investigations.
This preface to the republication of the original article
provides key background information and references to
contributions by the many now-famous clinical investiga-
tors who were involved with pilot studies. In addition, the
USPHS recommendations are critically reviewed. Clinical
evaluation of restorative procedures requires (a) choices of
clinically relevant criteria, (b) assessment using simple
nominal scales, (c) calibration of evaluators, (d) two inde-
pendent evaluations, and (e) nonparametric statistic anal-
ysis that recognizes the patient (and not the restoration) as
the independent variable. Only portions of those proce-
dures are being preserved in current clinical investigations.
USPHS criteria continue in use until today as part of
routine clinical evaluation and as components of standards
programs such as the ADA acceptance program. However,
in addition, USPHS-like criteria have been appended over
the years to produce “modified USPHS guidelines.” These
additional criteria include parameters such as postoperative
sensitivity, fracture, interproximal contact, occlusal con-
tact, and others. The combination of the original and
modified USPHS criteria now have been accepted world-
wide but are not necessarily uniformly applied. They
constitute the foundation for current considerations of
further development of clinical assessment methods for
dental restorative procedures.
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Justification for reprinting this classic article
Few if any methodological studies in the dental restorative
materials field have been cited more often and had a greater
scientific impact than the US Public Health Service
(USPHS) Guidelines developed by Cvar and Ryge [9]. A
simple search of PubMed (August 26, 2005) for (USPHS
or Ryge) AND criteria AND (dental OR dentistry) pro-
duced 353 references. This paper spelled out the criteria
and defined a system for the clinical evaluation of dental
restorative materials. This evaluation system was also
known as the “Ryge criteria,” of which the original cate-
gories were color match, cavosurface marginal discolor-
ation, anatomic form, marginal adaptation, and caries.
During the last 40 years, these criteria have been slightly
modified by several authors, adjusting them to their special
needs, and the list of criteria has been expanded to include
other items of interest. The expanded list contains criteria
for surface texture, postoperative sensitivity, proximal
contact, occlusal contacts, fracture, and others. These mod-
ifications are explained and readily accessible in the current
dental scientific literature. However, the original research
report by Cvar and Rgye is very difficult to access.
There are only three remaining archived copies of this
archived publication. New investigators around the world
have essentially no access to its content, despite their
interest in utilizing the USPHS system. They must rely on
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secondary descriptions of this work or restatements of its
content. In today’s world, there is tremendous emphasis
(and increasing governmental financial support) on clinical
research. Evidence of this is demonstrated by the extraor-
dinary multimillion-dollar recent expenditures by the
National Institutes of Health (NIH) and National Institute
of Dental and Craniofacial Research (NIDCR) on invest-
ment into and expansion of clinical research systems as part
of the NIH Road Map [18].
Within this context and within these special discussions
being currently held about improving clinical research
techniques, we considered it extremely important to make
this original article by Cvar and Ryge available once again
to all clinical research investigators. The original research
report was released in 1972 as a technical publication by
the US Department of Health, Education, and Welfare. It is
only appropriate that this research report be republished in
a journal that is, by its name, devoted to “clinical oral
investigations.”
Rereading this 1972 article reveals that the clinical
research challenges raised in the middle of the last century
clearly are still valid and even more timely in the current
climate favoring clinical research some 40 years later.
Consider the emphases of the original authors: “Many
researchers are acutely aware that clinical performance
cannot be directly predicted from laboratory tests, ....” or
“In recent years, their task (of the dentist choosing a
suitable material) has been complicated by the introduction
of dozens of new restorative materials.” Today, we can
replace the word “dozens” by the word “hundreds”. This
makes the problem for understanding materials changes
and differences even more relevant.
Our feeling is that this article may be regarded as the
original basis for the scientific evaluation of the clinical
performance of dental restorative materials. Our specific
purposes in reprinting this original article are fourfold.
First, this process will allow access by all clinical re-
searchers to the original content. Second, it will help em-
phasize the key value of portions of the original system,
such as “training and calibration,” which have been all but
forgotten. Third, it will stimulate modern discussion about
the need for clinical research for everything in dentistry.
Fourth, it will be a starting point for redefining the most
suitable criteria for testing newer dental restorative
materials.
Environment for the development of the USPHS
guidelines
A great deal of understanding of the value of this “classic
article” comes from appreciating the background and
history of this particular research. Until this point in dental
history, clinical research in restorative dentistry had not
been organized. No one was sure what to measure or how
to report their observations. Work toward these ends began
for Cvar and Ryge in an earlier paper in August 1964, as
noted by the authors in the “Acknowledgments” section of
their original article. The environment for the beginnings
of this work was the Materials and Technology Branch,
Division of Dental Health, which existed at the USPHS
Hospital in San Francisco and which Ryge directed from
1964 to 1971. The first mention of this sort of clinical
research effort was revealed in an early conference in 1965
by Ryge [11] and considered the dilemma for investiga-
tors. While there was interest in clinical research of
restorative dental materials, there was very little history of
systematic activity in clinical research. There was great
uncertainty as to what categories of information to collect.
No system of direct oral evaluation had been developed
yet.
As with any new system or methodology or technique,
Ryge recognized that this effort required very careful
development and testing. In the last part of the 1960s,
Ryge was in a unique place to begin to develop this work,
the USPHS Hospital in San Francisco. After this ground-
breaking effort, Gunnar Ryge moved on to the University
of the Pacific and was succeeded at the USPHS (at the
Presidio) by Joe Moffa. Moffa adopted and utilized a large
part of this system in extensive clinical trials for the next
20 years until he retired and the hospital was closed.
During that time, a number of remarkable individuals who
would become famous in their own rights worked with
Moffa, became calibrated, utilized the system in their own
research projects, and perpetuated the effort. In light of
Moffa’s special role, it is only suitable to listen to him tell
his view of this story. (personal communication; e-mail;
2004.09.10]
“It was a typical foggy San Francisco day in 1966 when
Dr. Gunnar Ryge, as the newly appointed Director of
the Materials and Technology Branch of the U.S.
Public Service Health Dental Health Center, challenged
a group of young clinical dentists, supportive staff, and
a recent graduate from Ralph Phillip’s biomaterials
graduate program [Dr. Joe Moffa], with the seemingly
impossible task of devising a system to quantify the
clinical performance of dental restorative materials.
[Early discussions included Dr. Bjorn Hedegard and Dr.
Bruce E. Johnson.] The original team consisted of Dr.
Gunnar Ryge, Dr. JamesMcCune, Dr. RichardWebber,
Dr. Rudolph Micik, Dr. Larry Gettleman, Mr. Jack
Cvar, Ms. Peggy Benton, [Miss Mildred Snyder,] and
Dr. Joseph P. Moffa.”
“From the onset, as dental clinicians and from a purely
empirical viewpoint, the group had little disagreement
at to what constituted either an excellent clinical res-
toration or a defective restoration, but the group soon
realized two major problems. First, the majority of
clinical restorations fell between these two extremes
and seemed to represent some sort of inexplicable
continuous multi-dimensional variable. Second, the
approach to the challenge of in-vivo measurement of
clinical performance with hampered by the prejudices
of prior in-vitro testing of the mechanical and physical
properties of dental restorative materials. In the
laboratory one could place a standardized specimen
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in an Instron Universal Testing machine and obtain
discrete numbers which were amenable to conven-
tional parametric statistics. The group soon became
aware that the clinical environment was not that
amenable to the traditional parametric measurement
systems.”
“The group adopted the approach that this challenge
was no different from the solution of any other so-
called complex ‘insoluble’ problem—identify the
elements, break them down, and solve each element
individually. Thus, for subjective clinical assessment
of restorations which were either excellent or grossly
defective, the key was to identify the individual
components of that total subjective judgment. After
some minor bickering as to appropriate terminology
there was unanimity that color match, marginal
discoloration, marginal integrity, anatomic form, and
dental caries represented the five multi-dimensional
parameters which were the major influences on our
clinical judgment of a restoration’s success or failure.
It would appear that the team’s first success was that it
had broken down the subjective clinical judgments to
a very basic nominal scale.”
“Having identified the major components of clinical
judgment which impact upon a restoration’s clinical
performance, the team’s next challenge was to draw
upon joint clinical experiences and create a descriptive
clinically relevant scale of increased severity within
each nominal parameter. In order to reduce the
possibility of recorder error, phonetic names were
attributed to each of the scale units, i,e alfa, bravo
charlie, delta, etc. [These names are part of the US Air
Force system of stating alphabetic letters during radio
communications. Alfa is NOT a misspelling of the
Greek letter, “α.”] The measurement system which
finally evolved implied increased severity of each
nominal class and was based upon an ordinal or
ranking system.”
“Although Alfa, Bravo and Charlie were easy to
pronounce... they were only just names and not
numbers. A Bravo restoration wasn’t twice as bad as
an Alpha and Charlie wasn’t three times as severe as
Alpha restoration. We couldn’t assign a number 1 to
Alfa, 2 to a Bravo, and a 3 to a Charlie and calculate
means, standard deviations, etc. These were no longer
nice neat numbers which could be analyzed paramet-
rically. The group found themselves suddently in the
then unfamiliar world of non-parametric statistics and
had to rely on their statistician, Mr. Jack Cvar, to bring
light to this brave new world.”
“They realized quite early that in order to use any
measuring system in a realiable way, it was important
that all prospective clinical evaluators be calibrated
systematically. The purpose of the calibration proce-
dure was two fold. First, calibration should eliminate
candidates who lacked the visual acuity, discrimina-
tion, and/or familiarity with the scale. Second, cali-
bration should prevent individual drift in judgmental
assessment over time.”
“In retrospect, I know I [Dr. Joe Moffa] speak for all
the members of the initial team who were challenged
by Dr. Gunnar Ryge’s acute perception for the need for
a quantitative measure of clinical performance. The
team was motivated by his persistence, guidance and
overall enthusiasm and were proud to be there when
the page was blank. We fully realize that much more is
still be written in the unending quest for measures of
clinical performance.”
Overview of the article
This description by Moffa of the events is crucial in
understanding the core value of this publication. The
USPHS guidelines exist as a “system of clinical evaluation
steps” that (a) defines key intraoral events to be measured
for any clinical trial, (b) describes or ranks the key clinical
stages of change, and (c) provides a calibration system for
evaluators who might be involved in clinical trials using the
system. The actual article carefully documents all of the
stages in the development of the guidelines. As the authors
note, “Further experience with the rating scales in actual
clinical studies led to the consolidation of anterior and
posterior criteria, which had been developed separately,
and to the deletion of certain rating scales which failed to
yield useful information. The rating scales which were
finally adopted are for color match, cavosurface marginal
discoloration, anatomic form, marginal adaptation, and
caries.” At one point, the authors suggest that the system
could have many applications “... including assess[ment of]
the work of dental students... [or] comparing two different
dental materials or two different dental procedures
involving the same patient.” In addition to the information
about ranking, the authors offered numerous comments on
appropriate methods of devising clinical trials and applying
the rating scales.
To make the rating process work, it was and still is
crucial to train and continually calibrate examiners. This
appears to have been lost as part of the process over many
years since the USPHS guidelines were originally pub-
lished. While some might argue that it is not necessary to
calibrate trained clinicians, it has constantly been demon-
strated that there is wide variability in the diagnosis of
dental problems because of differences in perception and
importance among individuals [7]. This uncertainty is
clearly a challenge for ratings such as detection of caries.
For training, it is therefore necessary that research teams
have a set of models or photographs that guide them in the
calibration process. Calibration should have a minimum
performance expectation such as 85% correct judgment in
the calibration phase. Clinical trials should include a
declaration of the training and calibration processes, as
well as record keeping for those processes.
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What has been missing for the most part over the years is
a well-defined set of models or photographs for training
and calibrating individuals from diverse clinical research
teams to arrive at the same level of judgment so that results
of clinical trials might truly be comparable. This is a major
deficit for current clinical research efforts. Part of this
problem might disappear if adequate and similar controls
were used routinely in clinical trials. Yet controls rarely
exist for so much of the current clinical research. Nagging
problems of the expenses have all but eliminated inclusion
of controls. One of the great strengths of the USPHS
guidelines has been that if investigators are adequately
calibrated then controls theoretically might not matter.
During the last 15 years, the American Dental Associ-
ation (ADA) has continually evolved a series of ADA
Acceptance Program Guidelines for clinical trials for such
things as bonding systems and posterior composites[1–6].
These guidelines rely on the USPHS categories as the
primary information about clinical performance. However,
even these ADA guidelines have not defined a requirement
for training and calibration.
Another part of the original USPHS guidelines was a
requirement for at least dual examination with a process of
resolving differences when they arose. Clinical trials during
the early days diligently adhered to calibration and dual
examination [16]. Costs and inconvenience largely have
driven out this process as well. Recalls tend to be done by
only one evaluator and perhaps reviewed later by a second
using the photographic record of the patient appointment.
Using an evaluator who is trained and calibrated produces
an 85% likelihood that the rating is correct. Under the
original system using two trained evaluators, the likelihood
of correct ratings would become at least 97.75% [85%+
(85%×15%)].
Cvar and Ryge included cautions in the “Appendix” to
their article “that teeth of any given patient could not be
treated as independent of one another” and “that some
method must be devised to represent each patient by a
single score....” Clinical research trials of recent time have
never really dealt with this problem. All restorations are
treated as independent. While ADA Guidelines for clinical
trials discourage the use of more than two test restorations
per patient, there is still strong potential for biasing the
results.
Cvar was quick to point out that categories of evaluation
included ratings or rankings that should only be analyzed
as nonparametric data. There was no presumption that the
changes from alfa-to-bravo or bravo-to-charlie could be
considered equal in difference. There was no presumption
that changes must occur in a single direction (e.g., from
alfa-to-bravo-to-charlie), and reverse changes have been
reported [17]. In fact, it has not been uncommon for cat-
egories such as color matching to go the opposite direction.
A bravo could change into a charlie. In the original design,
results were reported as percentage of alfa, bravo, and
charlie ratings.
Often, the ratings (alfa, bravo, and charlie) have been
abbreviated asA, B, and C, respectively. For some categories
such as caries, there is no intermediate rating. The patient
either has caries associated with the restoration (C) or does
not (A). The original Ryge category of caries used only the
ratings of alfa (A) and bravo (B) to designate this, but most
investigators have changed this choice to alfa (A) and charlie
(C). The latter parallels the meaning of other categories in
which charlie (C) means clinically unacceptable.
While it might seem that a charlie (C) rating should
dictate immediate replacement of a restoration, that does
not happen immediately under many circumstances.
Generally, the clinical trial team determines the risk of
the failure to the patient. Under some circumstances such as
a color change to charlie (C), there is no risk, and so the
restoration may not be replaced until the end of the study.
This begs another interesting question. Are the USPHS
categories all equal in weight or affect in decision-making?
The answer is clearly no. Therefore, there is no practical
way to pool results across categories or at least none has
been shown to be possible to date.
In light of the many possible outcomes, an ADA panel of
consultants and advisors developed the ADA Acceptance
Program Guidelines for clinical trials. The approach was to
choose to define acceptable outcomes as less than a certain
percentage of C or charlie scores (e.g., <10% charlie at
3 years) in certain categories only. Other categories might
be tracked but might not lead to any decision about overall
restoration acceptability. Many investigators have chosen
to report the same data alternatively in publications in
terms of the percentage of restorations still showing clinical
excellent performance (i.e., percent alfa or %A) after
various periods of time. Since almost all restorations at
baseline start as alfa, the second approach presumably
tracks the changes as trends toward failure. There is no
right or wrong reporting method, but it would help if
current clinical researchers would adopt a more standard-
ized approach.
Variants and modified versions of the USPHS guidelines
Almost as soon as the original articles about USPHS guide-
lines were published, Ryge set out to consider expanding
the number of rating levels and testing the system for
applications beyond clinical research per se. Two note-
worthy variations arose. One included an additional
classification of delta (D) for some of the guidelines [12,
13, 15] A second variation proposed utilizing the same
schema for evaluating clinical practice quality [14] but
shifting to the ratings of romeo (R), sierra (S), tango (T),
and victor (V) [12, 13, 15]. For the most part, these tightly
paralleled the A, B, C, and D system.
In the early 1980s, workers at several universities
[Indiana University (Ralph W. Phillips, Marjorie Swartz,
Jim Setcos), University of North Carolina (Karl F.
Leinfelder, Duane F. Taylor, Aldridge D.Wilder, Jr., Harald
O. Heymann, Stephen C. Bayne), University of Texas at
San Antonio (E. Steven Duke), and others elsewhere
(David J. Eick, Mal Jendresen, Armand Lugassy)] began to
extend the number of USPHS categories of direct eval-
uation. Instead of the original five categories (caries, color
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match,...), there was interest in parameters such as occlu-
sion, postoperative sensitivity, fracture, retention, and
others. More and more clinical trials began to report an
expanded list of clinical performance evaluations. For lack
of any better title, these modified lists became known as the
modified USPHS guidelines. For the most part, the criteria
for the original five categories remained exactly the same
and those categories were included, but now there were as
many as nine new categories as well that mimicked the
original rating system in design [alfa (A), bravo (B), and
charlie (C)]. Unfortunately, authors from different clinical
research teams did not always use the same definitions for
assigning these new ratings. Thus, it became almost a
requirement to declare the categories and define the ratings
as part of all publications. This is still common today.
Early adoption of the USPHS guidelines
The core group of contributors to the original USPHS
system, as well as the few dental clinical research centers
for investigating restorative dental materials (Presidio,
Indiana, University of North Carolina, Oregon, and others)
immediately adopted the original USPHS guidelines for
their work. There is early evidence of this in the literature.
Mal Jendresen and Ralph Phillips probably did the very
first official clinical trial based on the new guidelines while
studying zinc oxide-eugenol (ZOE) cements that were
being modified to develop intermediate restorative materi-
als (IRM) [10]. Many others were exploring new types of
materials evaluated with the system [8]. During this same
time period, Joe Moffa succeeded Gunnar Ryge at the
Presidio in San Francisco and began to significantly
expand the clinical research operation. Literally dozens
of clinical trials were conducted by Moffa over the next
10–15 years utilizing the USPHS criteria.
While Ryge and Cvar did publish several articles on the
system and statistical evaluation of clinical data obtained
by the use of the rating scales, few articles were published
of any of the comparative pilot studies from the original
article. Clinical findings were presented annually at the
International Association for Dental Research (IADR)
meetings between 1965 and 1970 on spherical, fine grain,
and micro amalgam alloy systems and some of the very
early composite materials. Spherical alloys, composites,
and new cements were being introduced to the market, with
little more than laboratory properties being used to promote
their acceptance.
Where are these early pioneers and adopters now?
Jack Cvar was a statistician and not a dentist. He only
published six articles that are referenced in PubMed and
passed away years ago from being a very heavy smoker.
The rest of the team were young Commissioned Officers
with the US Public Health Service and were selected to
staff the new branch. Dr. Richard Weaver is now the As-
sociate Director for the Center for Educational Policy and
Research at the American Dental Education Association in
Washington DC. Dr. Joe Moffa is retired in living in Fair
Oaks Ranch in Texas.
Many of the related players who conducted early clinical
research trials based on these methods are retired or
consultants but some are still involved in research. Here is
some information on some of the group. Dr. Mal Jendresen
is retired and living in Sausalito, CA. Dr. Larry Gettleman
is a professor at the University of Louisville and actively
involved in the clinical research of maxillofacial materials.
Dr. David J. Eick is the Chair of the Department of Oral
Biology at UMKC in Kansas City, MO. Dr. Al Guckes
is the Assistant Dean for Predoctoral Education at the
University of North Carolina. Dr. Karl Leinfelder is retired
as a Professor Emeritus from the University of Alabama
and an Adjunct Professor at the University of North
Carolina and currently living in Chapel Hill, NC. Dr. Jim
Setcos is living in England. Dr. Steven Duke is Director of
the Central Texas VA Health Care System in Georgetown,
TX. Dr. Jack Mitchem is retired but is still active as an
Adjunct Professor at the Oregon Health Science Unit
in Portland, OR. Dr. Ralph Phillips passed away in 1991
before retirement from Indiana University Dental School.
Ms. Marjorie L. Swartz is retired and living in Indiana.
Dr. P.O. Glantz is retired and living in Malmo, Sweden.
Dr. Ivar Mjor is a professor in Operative Dentistry at
the University of Florida in Gainesville, FL. Dr. Nairn
Wilson is Dean of the GKT Dental Institute in London.
Dr. Gunnar Ryge (shown in the image below) passed
away in 1991 after a brilliant career in dental research that
was completed at the University of the Pacific. However,
his influence in this process of dental clinical research will
be forever honored for the scientific method that he used to
devise the USPHS guidelines in his work with Jack Cvar.
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